In addition to directly damaging the lung epithelium, ROS/RNS may also favour the development of pulmonary fibrosis by altering the expression of mediators implicated in the pathogenesis of IPF, such as the pro-fibrotic growth factor, transforming growth factor β (TGF-β). Here, TGFB1 is linked to pulmonary fibrosis.